Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.
about
Diagnosis and management of extranodal NK/T cell lymphoma nasal type.Epigenetic inactivation of the miR-124-1 in haematological malignancies.GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.Extranodal NK/T-cell lymphoma nasal type: efficacy of pegaspargase. Report of two patients from the United Sates and review of literature.Natural killer/T-cell lymphoma-associated hemophagocytic syndrome: A case reportPrognostic markers in peripheral T-cell lymphomaExtranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal typeEpigenetic inactivation of the hsa-miR-203 in haematological malignancies.Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferationsUtility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis.The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsRadiotherapy combined with chemotherapy versus radiotherapy alone for early stage nasal natural killer/T-cell lymphoma: a meta-analysis.High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma.Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.Natural killer-cell malignancies: diagnosis and treatment.Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal typeThe pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphomaDecreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type.Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs.Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphomaClassification and treatment of rare and aggressive types of peripheral T-cell/natural killer-cell lymphomas of the skin.Predicting the outcome in non-Hodgkin lymphoma with molecular markers.L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphomaA unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma.Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma.Identification of genuine primary pulmonary NK cell lymphoma via clinicopathologic observation and clonality assay.Predictors of survival of natural killer/T-cell lymphoma, nasal type, in a non-Asian population: a single cancer centre experienceExtranodal NK / T-cell lymphoma, nasal type: new staging system and treatment strategies.High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies.Utility of baseline, interim and end-of-treatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase.Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment.The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma.Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type.Risk stratification in extranodal natural killer/T-cell lymphoma.Diagnosis and management of natural killer-cell malignancies.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).
P2860
Q30249309-7CEF07F1-25F7-412D-9A00-591999817DDFQ31008825-05BEC302-FA70-4215-BB22-36C1FDA019D2Q33429990-25B3F9EA-D0C4-4DE1-9612-DB9BB4BDAA9DQ33620726-5059E3F5-2707-4A1B-A678-E2377CBBDBDFQ33844160-54C13101-8E2F-4BAE-860B-6543A06EB5AAQ34166857-8B3EB7F5-390C-41A4-BACE-5E6DF33BC5F6Q34293085-4142404B-EC64-407F-B224-9A0C6FD50969Q34749502-3E8A8C22-272D-45F7-A8E0-B2A4F0F2B58CQ35216337-C94C0113-5DA0-4353-B22A-30C39F306265Q35232848-29CA4BEE-2889-4CA8-8935-1B1A27E0F1D7Q35530868-6DDDA28C-22FD-4B6C-90CE-458601FC85E2Q35624432-446E6B75-794D-4049-AB9C-8160F1C67977Q35630934-57CC72E1-AB82-45B9-B969-2676744DF4B3Q35975572-24C130A5-A6DF-493C-AD68-C8513E098947Q36156508-A8B7F762-387C-4290-9944-3B7C6DEE3F25Q36265596-1E448A24-C3E7-4E29-A319-425291247D6BQ36594091-BBA70032-73CE-4C10-B420-9E84DC47EE8CQ36663469-920168A8-9CD1-4EEB-99DE-F37DCD6DE077Q36716218-25840DA4-E4BF-4F51-A3BE-3CA62864A5CBQ36757012-7366266D-C55E-46B9-8FCB-75B56FD37F38Q36760583-3102B3C6-28E4-41D4-B609-E94024D09CFBQ36771221-03C51EB9-E030-4195-A58B-C5ABB17022E9Q36780164-6A33364C-C6D6-4D9B-879E-CE7798C6A35CQ36954142-7BDB57A7-8DEC-4CD1-87C9-532910BD3D9CQ37072876-19E9FB26-4EC4-4EE7-93AE-ADFF98D58159Q37243101-42CBF81C-AE21-43CB-8403-0FB1E53558F7Q37321943-ED1562F9-E183-4E6A-AC56-66D88E397047Q37344483-4735C793-AEBE-45CD-8DC7-CC0D0E0F5D74Q37355453-0E6A051E-B31D-4397-89EB-5D6E36EA2206Q37458786-7DDC55BA-8093-4286-AD4A-596C2B12773BQ37598368-725324FC-B311-454C-81D1-510F392291E8Q37600612-A901C77B-C60A-498A-935B-24E7830CECCAQ37602246-CEFBD14D-ABE8-4C3B-A2E1-D5D66C78040EQ37626051-3DB6AFB2-9B06-4DF7-AAE9-526ED9F39409Q37629033-58CA55E3-8A72-496C-A081-F9CFAC3B46E0Q37702163-0FCDA565-D912-4BCF-B29C-304B2E34BA07Q37706167-28D1CA6A-7EA0-4572-BCE4-2F13EDDBC684Q37788238-A655592D-9D79-43AC-92ED-3DB72C5FAA50Q37810280-476191F2-6A16-4CA7-914F-3FD3B02DD2EDQ37863688-67302105-5FCB-4FFF-90F7-F95EBFD849A9
P2860
Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Primary nasal natural killer c ...... nternational Prognostic Index.
@en
Primary nasal natural killer c ...... nternational Prognostic Index.
@nl
type
label
Primary nasal natural killer c ...... nternational Prognostic Index.
@en
Primary nasal natural killer c ...... nternational Prognostic Index.
@nl
prefLabel
Primary nasal natural killer c ...... nternational Prognostic Index.
@en
Primary nasal natural killer c ...... nternational Prognostic Index.
@nl
P2093
P1433
P1476
Primary nasal natural killer c ...... nternational Prognostic Index.
@en
P2093
Albert K W Lie
Carolyn Choy
Chor-Sang Chim
Chun-Chung Yau
Raymond Liang
Shing-Yan Ma
Wing-Yan Au
Yok-Lam Kwong
P304
P356
10.1182/BLOOD-2003-05-1401
P407
P577
2003-08-21T00:00:00Z